BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 32852845)

  • 1. N-glycome analysis detects dysglycosylation missed by conventional methods in SLC39A8 deficiency.
    Park JH; Mealer RG; Elias AF; Hoffmann S; Grüneberg M; Biskup S; Fobker M; Haven J; Mangels U; Reunert J; Rust S; Schoof J; Schwanke C; Smoller JW; Cummings RD; Marquardt T
    J Inherit Metab Dis; 2020 Nov; 43(6):1370-1381. PubMed ID: 32852845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, molecular and glycophenotype insights in SLC39A8-CDG.
    Bonaventura E; Barone R; Sturiale L; Pasquariello R; Alessandrì MG; Pinto AM; Renieri A; Panteghini C; Garavaglia B; Cioni G; Battini R
    Orphanet J Rare Dis; 2021 Jul; 16(1):307. PubMed ID: 34246313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A SLC39A8 variant causes manganese deficiency, and glycosylation and mitochondrial disorders.
    Riley LG; Cowley MJ; Gayevskiy V; Roscioli T; Thorburn DR; Prelog K; Bahlo M; Sue CM; Balasubramaniam S; Christodoulou J
    J Inherit Metab Dis; 2017 Mar; 40(2):261-269. PubMed ID: 27995398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLC39A8 Deficiency: A Disorder of Manganese Transport and Glycosylation.
    Park JH; Hogrebe M; Grüneberg M; DuChesne I; von der Heiden AL; Reunert J; Schlingmann KP; Boycott KM; Beaulieu CL; Mhanni AA; Innes AM; Hörtnagel K; Biskup S; Gleixner EM; Kurlemann G; Fiedler B; Omran H; Rutsch F; Wada Y; Tsiakas K; Santer R; Nebert DW; Rust S; Marquardt T
    Am J Hum Genet; 2015 Dec; 97(6):894-903. PubMed ID: 26637979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry glycophenotype characterization of ALG2-CDG in Argentinean patients with a new genetic variant in homozygosis.
    Papazoglu GM; Cubilla M; Pereyra M; de Kremer RD; Pérez B; Sturiale L; Asteggiano CG
    Glycoconj J; 2021 Apr; 38(2):191-200. PubMed ID: 33644825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The schizophrenia risk locus in SLC39A8 alters brain metal transport and plasma glycosylation.
    Mealer RG; Jenkins BG; Chen CY; Daly MJ; Ge T; Lehoux S; Marquardt T; Palmer CD; Park JH; Parsons PJ; Sackstein R; Williams SE; Cummings RD; Scolnick EM; Smoller JW
    Sci Rep; 2020 Aug; 10(1):13162. PubMed ID: 32753748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and genotypic spectrum of congenital disorders of glycosylation type I and type II.
    Al Teneiji A; Bruun TU; Sidky S; Cordeiro D; Cohn RD; Mendoza-Londono R; Moharir M; Raiman J; Siriwardena K; Kyriakopoulou L; Mercimek-Mahmutoglu S
    Mol Genet Metab; 2017 Mar; 120(3):235-242. PubMed ID: 28122681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALG12-CDG: novel glycophenotype insights endorse the molecular defect.
    Sturiale L; Bianca S; Garozzo D; Terracciano A; Agolini E; Messina A; Palmigiano A; Esposito F; Barone C; Novelli A; Fiumara A; Jaeken J; Barone R
    Glycoconj J; 2019 Dec; 36(6):461-472. PubMed ID: 31529350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transferrin variants: pitfalls in the diagnostics of Congenital disorders of glycosylation.
    Zühlsdorf A; Park JH; Wada Y; Rust S; Reunert J; DuChesne I; Grüneberg M; Marquardt T
    Clin Biochem; 2015 Jan; 48(1-2):11-3. PubMed ID: 25305627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MALDI-MS profiling of serum O-glycosylation and N-glycosylation in COG5-CDG.
    Palmigiano A; Bua RO; Barone R; Rymen D; Régal L; Deconinck N; Dionisi-Vici C; Fung CW; Garozzo D; Jaeken J; Sturiale L
    J Mass Spectrom; 2017 Jun; 52(6):372-377. PubMed ID: 28444691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAN1B1-CDG: Three new individuals and associated biochemical profiles.
    Sakhi S; Cholet S; Wehbi S; Isidor B; Cogne B; Vuillaumier-Barrot S; Dupré T; Detleft T; Schmitt E; Leheup B; Bonnet C; Feillet F; Muti C; Fenaille F; Bruneel A
    Mol Genet Metab Rep; 2021 Sep; 28():100775. PubMed ID: 34141584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel transferrin E592A variant impairs the diagnostics of congenital disorders of glycosylation.
    Park JH; Zühlsdorf A; Wada Y; Roll C; Rust S; Du Chesne I; Grüneberg M; Reunert J; Marquardt T
    Clin Chim Acta; 2014 Sep; 436():135-9. PubMed ID: 24875750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COG1-congenital disorders of glycosylation: Milder presentation and review.
    Salazar M; Miyake N; Silva S; Solar B; Papazoglu GM; Asteggiano CG; Matsumoto N
    Clin Genet; 2021 Sep; 100(3):318-323. PubMed ID: 33960418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALG12-CDG: An unusual patient without intellectual disability and facial dysmorphism, and with a novel variant.
    de la Morena-Barrio ME; Sabater M; de la Morena-Barrio B; Ruhaak RL; Miñano A; Padilla J; Toderici M; Roldán V; Gimeno JR; Vicente V; Corral J
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1304. PubMed ID: 32530140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal transferrin patterns in congenital disorders of glycosylation with Golgi homeostasis disruption: apolipoprotein C-III at the rescue!
    Raynor A; Vincent-Delorme C; Alaix AS; Cholet S; Dupré T; Vuillaumier-Barrot S; Fenaille F; Besmond C; Bruneel A
    Clin Chim Acta; 2021 Aug; 519():285-290. PubMed ID: 34022244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel ALG12 variants and hydronephrosis in siblings with impaired N-glycosylation.
    Hiraide T; Wada Y; Matsubayashi T; Kadoya M; Masunaga Y; Ohkubo Y; Nakashima M; Okamoto N; Ogata T; Saitsu H
    Brain Dev; 2021 Oct; 43(9):945-951. PubMed ID: 34092405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nationwide survey of PMM2-CDG in Italy: high frequency of a mild neurological variant associated with the L32R mutation.
    Barone R; Carrozzi M; Parini R; Battini R; Martinelli D; Elia M; Spada M; Lilliu F; Ciana G; Burlina A; Leuzzi V; Leoni M; Sturiale L; Matthijs G; Jaeken J; Di Rocco M; Garozzo D; Fiumara A
    J Neurol; 2015 Jan; 262(1):154-64. PubMed ID: 25355454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative quantification of plasma N-glycans in type II congenital disorder of glycosylation patients by mass spectrometry.
    Barbosa EA; Fontes NDC; Santos SCL; Lefeber DJ; Bloch C; Brum JM; Brand GD
    Clin Chim Acta; 2019 May; 492():102-113. PubMed ID: 30776362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten years of screening for congenital disorders of glycosylation in Argentina: case studies and pitfalls.
    Asteggiano CG; Papazoglu M; Bistué Millón MB; Peralta MF; Azar NB; Spécola NS; Guelbert N; Suldrup NS; Pereyra M; Dodelson de Kremer R
    Pediatr Res; 2018 Dec; 84(6):837-841. PubMed ID: 30397276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary disorders of glycosylation in inborn errors of fructose metabolism.
    Quintana E; Sturiale L; Montero R; Andrade F; Fernandez C; Couce ML; Barone R; Aldamiz-Echevarria L; Ribes A; Artuch R; Briones P
    J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S273-8. PubMed ID: 19768653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.